| Clinical data | |
|---|---|
| Other names | Detrifluoromethylfluoxetine |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C16H19NO |
| Molar mass | 241.334 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
N-Methyl-PPPA, orN-methyl-3-phenoxy-3-phenylpropan-1-amine, is aserotonin-norepinephrine reuptake inhibitor (SNRI) which was developed byEli Lilly fromdiphenhydramine in the early 1970s while in search of newantidepressants, but was never marketed.[1][2][3] It is closely related structurally tofluoxetine,atomoxetine, andnisoxetine.[1][2][3]
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |